NPI: 1942554407 · CAPITOL HEIGHTS, MD 20743 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/06/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/06/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,414 | $258K |
| 2019 | 25,175 | $281K |
| 2020 | 20,755 | $268K |
| 2021 | 12,645 | $192K |
| 2022 | 9,754 | $220K |
| 2023 | 3,907 | $122K |
| 2024 | 649 | $40K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 31,699 | 2,307 | $1.15M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,668 | 1,658 | $202K |
| J1756 | Injection, iron sucrose, 1 mg | 6,132 | 1,363 | $15K |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,549 | 1,585 | $11K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 95 | 24 | $2K |
| A4657 | Syringe, with or without needle, each | 4,297 | 1,695 | $397.57 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 442 | 211 | $371.88 |
| 90674 | 80 | 66 | $184.05 | |
| 83970 | 1,158 | 960 | $154.71 | |
| 82728 | 800 | 710 | $50.24 | |
| 83550 | 841 | 744 | $17.79 | |
| G0008 | Administration of influenza virus vaccine | 73 | 60 | $17.59 |
| 83540 | 904 | 798 | $13.17 | |
| 85041 | 1,131 | 966 | $10.51 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 304 | 152 | $8.46 |
| 85048 | 1,111 | 954 | $8.39 | |
| 90662 | 15 | 12 | $0.00 |